Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-04

Clinical Trial Update: Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial comparing valsartan/amlodipine versus losartan in patients with stage 2 systolic hypertension; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cozaar (losartan)
  • Exforge (valsartan; amlodipine)

Snippet

Sponsor: Novartis | Conditions: Stage 2 Systolic Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-02-04